rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-29
|
pubmed:abstractText |
Genetic variation of inosine triphosphatase (ITPA) causing an accumulation of inosine triphosphate (ITP) has been shown to protect patients against ribavirin (RBV)-induced anemia during treatment for chronic hepatitis C infection by genome-wide association study (GWAS). However, the biologic mechanism by which this occurs is unknown.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1528-0012
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1314-21
|
pubmed:meshHeading |
pubmed-meshheading:21199653-Adenosine Triphosphate,
pubmed-meshheading:21199653-Adenylosuccinate Synthase,
pubmed-meshheading:21199653-Adolescent,
pubmed-meshheading:21199653-Adult,
pubmed-meshheading:21199653-Anemia,
pubmed-meshheading:21199653-Antiviral Agents,
pubmed-meshheading:21199653-Enzyme Activation,
pubmed-meshheading:21199653-Erythrocytes,
pubmed-meshheading:21199653-Genetic Variation,
pubmed-meshheading:21199653-Genotype,
pubmed-meshheading:21199653-Guanosine Triphosphate,
pubmed-meshheading:21199653-Hepatitis C, Chronic,
pubmed-meshheading:21199653-Humans,
pubmed-meshheading:21199653-Inosine Triphosphate,
pubmed-meshheading:21199653-Pyrophosphatases,
pubmed-meshheading:21199653-Ribavirin,
pubmed-meshheading:21199653-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function.
|
pubmed:affiliation |
Center for Human Genome Variation, School of Medicine, Duke University, Durham, North Carolina, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|